Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersBusiness Wire · Sep 30, 2026
Retractable Technologies, Inc. Supports Senator Blackburn's ONSHORE Manufacturing ActBusiness Wire · Sep 3, 2026
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit VolumesZacks Investment Research · Aug 20, 2026
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026Business Wire · Aug 14, 2026Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps.